Tree of Heaven IgE Test · Blood

If your nose runs, your eyes itch, or your asthma flares between May and July and standard allergy panels keep coming back unremarkable, the cause might be a tree that most allergy panels do not test for. Tree of heaven (Ailanthus altissima) is an invasive species spreading across cities and suburbs worldwide, and its pollen can trigger genuine allergic sensitization.

This blood test looks for IgE (immunoglobulin E) antibodies your immune system has made specifically against tree of heaven pollen proteins. A positive result tells you that your immune system has recognized this pollen as a threat and may be primed to react to it during pollen season.

What This Test Actually Measures

IgE is one of five antibody classes your immune system produces. Unlike the antibodies that fight infections, IgE specializes in triggering immediate allergic reactions. When you have allergen-specific IgE in your blood, it means certain immune cells (B cells and the plasma cells they become) have learned to recognize a particular substance and respond to it.

Each allergen-specific IgE antibody has variable binding regions tailored to one target. The version measured by this test recognizes proteins found in tree of heaven pollen. When that pollen enters your airways, the IgE attaches to immune cells lining your nose, eyes, and lungs (mast cells and basophils, which store inflammatory chemicals), which then release histamine and other compounds that cause the classic allergy symptoms.

Why Tree of Heaven Matters as an Allergen

Tree of heaven has spread aggressively across North America, Europe, and Asia, often dominating disturbed urban areas, roadsides, and abandoned lots. It releases pollen from early June through mid-July in temperate climates, with airborne concentrations reaching meaningful levels during peak season in measured studies.

A clinic study in Leipzig, Germany tested 138 children and adults whose atopic disease worsened during May through July. About 42% had detectable IgE antibodies to tree of heaven pollen in their blood. The rates were similar between children and adults, suggesting this is not a sensitization that builds up with decades of exposure but can develop at any age.

Among people with positive tree of heaven IgE, the majority had no cross-reactivity to common allergen components found in many other pollens (profilin, polcalcin, and CCD, which are shared building blocks across plant pollens). This means most positive results reflect genuine sensitization to tree of heaven itself, not a false signal from antibodies generated against birch, grass, or other related pollens.

Conditions Linked to Pollen-Specific IgE

Elevated IgE against airborne pollens is consistently linked to a cluster of allergic conditions in human studies. The Leipzig study population was selected specifically because their atopic disease worsened during tree of heaven pollen season, with symptoms including allergic rhinitis, conjunctivitis, and asthma flares.

• Allergic rhinitis and rhinoconjunctivitis: the most direct link, with sneezing, congestion, itchy eyes, and post-nasal drip during pollen exposure.
• Asthma: pollen-specific IgE is associated with asthma symptoms, especially seasonal worsening, and many people with allergic rhinitis also have airway involvement.
• Atopic dermatitis: people with eczema have higher numbers of IgE-producing immune cells in their blood and broader sensitization patterns.
• Oral allergy syndrome: some pollen sensitizations cross-react with proteins in fresh fruits and vegetables, causing mouth itching after eating them.

Why This Test Fills a Real Gap

Most commercial allergy panels include common trees like birch, oak, maple, and cedar, but tree of heaven is usually absent. Large IgE-profiling studies of inhaled allergens routinely use grouped tree-pollen mixes or component panels that do not include Ailanthus, leaving a testing gap in regions where the tree is widespread. If you live in an area where tree of heaven is common and your symptoms peak in June or July, a standard panel can easily miss the culprit.

The test uses an ImmunoCAP-style assay with a tree of heaven allergen extract. In published research, it showed low variability when run on the same day and between days, making it reproducible enough to track results over time.

Tracking Your Trend

A single IgE reading captures one moment in your immune response. Specific IgE levels can shift with ongoing exposure, allergen-avoidance behavior, or immunotherapy. If you are confirming a suspected diagnosis, one well-timed test is usually enough. If you are tracking the effect of an intervention, retesting matters more.

Get a baseline test, ideally during or just after pollen season when sensitization is most likely to show. If you start a treatment plan (allergen avoidance, immunotherapy, or anti-IgE therapy), retest in 6 to 12 months to see how your antibody level has changed. Stable or rising levels suggest ongoing exposure or active sensitization. Falling levels can signal that immunotherapy is working or that exposure has dropped.

When Results Can Be Misleading

Allergy blood tests have a few well-known traps. Understanding them helps you interpret your number accurately.

• Cross-reactivity with other pollens: IgE antibodies you developed against birch, grass, or other pollens can sometimes bind to similar proteins in tree of heaven, producing a positive result even if tree of heaven is not your true trigger. Component testing for profilin and polcalcin can help sort this out.
• Local allergy without serum IgE: some people have allergic symptoms driven by IgE produced in nasal tissue rather than circulating in blood. A negative serum test does not fully rule out tree of heaven allergy if your symptoms are convincing.
• Recent biologic therapy: dupilumab and other treatments targeting allergic inflammation can lower total IgE levels, which may affect specific IgE readings.
• Severe antibody deficiency: people with conditions like common variable immunodeficiency (CVID) cannot mount a normal IgE response, making allergy blood tests uninformative.

Reading Your Result and What to Do Next

A positive IgE to tree of heaven confirms sensitization but not necessarily clinical allergy. The result has to match your symptom pattern. If your symptoms peak when tree of heaven pollen is in the air (typically June and early July in temperate zones) and your test is positive, the connection is strong. If your symptoms occur at completely different times, the positive result may reflect cross-reactivity or silent sensitization.

If your test is positive and your symptoms match, consider expanding your workup. A full pollen IgE panel (birch, grass, ragweed, oak, and other regionally relevant trees) can identify whether tree of heaven is your only trigger or one of several. Total IgE gives context: very high total IgE points toward broad atopy, while normal total IgE with a single positive specific IgE makes the allergen-symptom link more specific. An allergist can correlate your results with skin-prick testing, which sometimes detects sensitization that blood tests miss and vice versa.

If your test is negative but your symptoms strongly suggest June-to-July pollen allergy, the diagnosis is not closed. Local IgE in nasal tissue can drive symptoms without showing in blood, and other less common pollens or molds may be the cause. An allergist can perform nasal provocation testing or other in-office workups.

Putting Tree of Heaven in Context

This is a focused, newer test rather than a routine clinical screening tool. It is most useful when you have a specific question: is this invasive tree species, which my standard allergy panel ignores, contributing to my symptoms? Used that way, it can close a real diagnostic gap that broad panels create. Used without context, it is just one data point among many.